Testicular tumors are one of those Step 1 topics that feels deceptively small… until you realize how often they’re used to test tumor markers, embryology, histology, risk factors, and treatment logic in a single vignette. If you can confidently separate seminoma vs nonseminomatous germ cell tumors (NSGCT) (and know what their markers and morphology imply), you’ll pick up a lot of easy points.
Big Picture: What Are Testicular Tumors?
Most testicular cancers are germ cell tumors (GCTs). They’re classically:
- Painless testicular mass
- Occur in young men (especially ages 15–35)
- Highly treatable, even with metastasis (especially seminoma)
Core Step 1 split
- Seminoma: tends to be uniform, radiosensitive, better prognosis
- Nonseminoma (NSGCT): more aggressive, often mixed, tends to have elevated AFP and/or β-hCG
First Aid cross-reference: Reproductive → Testicular cancer (Germ cell tumors, tumor markers, histology)
Risk Factors & Pathophysiology (Why It Happens)
Major risk factors (high-yield)
- Cryptorchidism (undescended testis)
- Risk persists even after orchiopexy (though surgery helps fertility and allows easier surveillance).
- Testicular dysgenesis / infertility associations
- Family history (less commonly tested, but fair game)
Underlying pathophys concept
Many germ cell tumors arise from germ cell neoplasia in situ (GCNIS) and share characteristic chromosomal changes (classically isochromosome 12p, often mentioned in more detailed resources).
Takeaway: On Step, the most testable “why” is cryptorchidism → increased risk of testicular cancer.
Clinical Presentation: How It Shows Up
Classic vignette
- Painless, unilateral testicular enlargement or firm mass
- May report “heaviness” or dull ache
Symptoms of metastasis (especially if advanced)
- Back pain (retroperitoneal lymph nodes)
- Cough/shortness of breath (lung mets)
- Gynecomastia (β-hCG–secreting tumors)
Key physical exam pearl
- Testicular cancer is a solid intratesticular mass.
- Transillumination is negative (helps distinguish from hydrocele).
Diagnosis: Step-by-Step Logic
1) Initial test
Scrotal ultrasound to confirm intratesticular solid mass.
2) Tumor markers (before orchiectomy)
Order serum markers before definitive surgery:
- AFP
- β-hCG
- LDH (less specific; correlates with tumor burden)
3) Definitive diagnosis & initial treatment
Radical inguinal orchiectomy (not trans-scrotal biopsy—risk of tumor seeding and altered lymphatic drainage).
4) Staging
- CT abdomen/pelvis (retroperitoneal nodes)
- Chest imaging (lungs)
First Aid cross-reference: Tumor markers (AFP, β-hCG), imaging and management principles in Testicular cancer section.
Tumor Markers: The Most Testable Table
| Tumor Type | AFP | β-hCG | LDH | High-yield clue |
|---|---|---|---|---|
| Seminoma | Normal | Sometimes ↑ | Sometimes ↑ | Uniform cells, radiosensitive |
| Embryonal carcinoma | Sometimes ↑ | Sometimes ↑ | ↑ | Aggressive, early hematogenous spread |
| Yolk sac tumor | ↑↑ | Normal | ± | Schiller-Duval bodies, children |
| Choriocarcinoma | Normal | ↑↑ | ± | Hematogenous spread, hemorrhagic |
| Teratoma | Usually normal | Usually normal | ± | Mature tissues; malignant in men |
| Mixed NSGCT | Often ↑ | Often ↑ | ↑ | “Mixed” is common—markers reflect components |
Marker rules you should memorize
- AFP is never elevated in pure seminoma.
If AFP is up, it’s nonseminoma or mixed. - β-hCG can be elevated in seminoma (syncytiotrophoblasts), but AFP should be normal.
- LDH is a “bulk” marker—less sexy, but shows up as “elevated LDH” in stem vignettes.
Seminoma: Hallmarks You’ll See on Step
Definition & pathology
A malignant germ cell tumor composed of relatively uniform germ cells.
Morphology (classic)
- “Fried egg” cells: large cells with clear cytoplasm and central nuclei
- Sheets/lobules separated by fibrous septa with lymphocytes (often described)
Clinical behavior
- Typically slow-growing
- Radiosensitive
- Often presents as a localized disease with excellent prognosis
Marker pattern
- AFP: normal
- β-hCG: may be mildly elevated
- LDH: may be elevated
High-yield association
- If the vignette screams seminoma but AFP is elevated → it’s not pure seminoma (think mixed tumor).
Nonseminomatous Germ Cell Tumors (NSGCT): Know the Components
NSGCTs include embryonal carcinoma, yolk sac tumor, choriocarcinoma, and teratoma, and are frequently mixed.
Embryonal carcinoma
- More aggressive than seminoma
- Often poorly demarcated with hemorrhage/necrosis
- Markers: AFP and/or β-hCG can be elevated
- Tends to metastasize earlier than seminoma
Yolk sac (endodermal sinus) tumor
- Most common testicular tumor in children
- Marker: AFP
- Histology: Schiller-Duval bodies (glomerulus-like structures)
Choriocarcinoma
- Marker: β-hCG
- Highly malignant, early hematogenous spread
- Classically metastasizes to lungs/brain
- Can cause gynecomastia and hyperthyroid-like symptoms (β-hCG can weakly stimulate TSH receptor—rare but a favorite “integrated” concept)
Teratoma
- Made of multiple germ layers (ectoderm/mesoderm/endoderm)
- In men, teratomas are considered malignant (even if histologically “mature”)
- Often part of mixed tumors
First Aid cross-reference: Germ cell tumor subtypes and their markers/histology in Testicular cancer; embryology tie-ins for yolk sac/choriocarcinoma.
Spread Patterns: The “Where Does It Go?” High-Yield Map
Lymphatic drainage (testis)
- Testes originate in the abdomen → drain to retroperitoneal (para-aortic) lymph nodes
Vignette clue: testicular cancer + back pain + retroperitoneal mass.
Hematogenous spread
- Especially prominent in choriocarcinoma (early blood-borne metastasis)
Treatment Principles (What Step 1 Expects)
Universal first step for suspicious testicular mass
- Radical inguinal orchiectomy
Seminoma
- Often treated with radiation (radiosensitive) and/or chemotherapy depending on stage.
NSGCT
- Generally less radiosensitive
- More often requires chemotherapy and/or surgical management (e.g., retroperitoneal lymph node dissection in select scenarios—more Step 2–leaning, but the principle is “more aggressive management than seminoma”).
The testable contrast
- Seminoma = radiosensitive, better prognosis
- Nonseminoma = more aggressive, earlier spread, chemo-heavy
High-Yield Vignette Patterns (Rapid Recognition)
Pattern 1: “Painless mass + fried egg”
- Seminoma
- Markers: AFP normal; β-hCG possibly mild ↑
Pattern 2: “Teen/child + AFP + Schiller-Duval bodies”
- Yolk sac tumor
Pattern 3: “Very high β-hCG + early lung/brain mets + hemorrhage”
- Choriocarcinoma
Pattern 4: “AFP elevated = rule out pure seminoma”
- Mixed tumor or NSGCT
Pattern 5: “History of cryptorchidism”
- Increased risk of germ cell tumors (seminoma or NSGCT)
Quick Comparison: Seminoma vs NSGCT
| Feature | Seminoma | NSGCT |
|---|---|---|
| Typical behavior | Indolent | More aggressive |
| Radiosensitivity | High | Lower |
| Prognosis | Better | Worse (but still often curable) |
| Markers | AFP normal, β-hCG sometimes ↑ | AFP and/or β-hCG often ↑ |
| Histology buzzwords | “Fried egg” | Schiller-Duval, hemorrhagic mets, mixed tissues |
Exam-Day Checklist (What to Recall Under Pressure)
- Ultrasound is the initial test for a scrotal mass.
- Radical inguinal orchiectomy is diagnostic + therapeutic.
- AFP elevated → not pure seminoma.
- β-hCG elevated can be seminoma (mild) or choriocarcinoma (often very high).
- Cryptorchidism is the classic risk factor.
- Para-aortic nodes are the primary lymphatic drainage site.